AbbVie to Acquire Allergan, Botox’s Maker, for $63 Billion

The deal would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira.

from NYT > Health https://nyti.ms/2NaofgR
via health&fitness